ReWalk Robotics Ltd. (NASDAQ:LFWD) Short Interest Up 21.3% in January

ReWalk Robotics Ltd. (NASDAQ:LFWD) was the target of a significant growth in short interest during the month of January. As of January 31st, there was short interest totalling 324,600 shares, a growth of 21.3% from the January 15th total of 267,500 shares. Based on an average trading volume of 668,000 shares, the short-interest ratio is currently 0.5 days. Currently, 3.6% of the company’s shares are sold short.

ReWalk Robotics Stock Up 10.9 %

NASDAQ LFWD traded up $0.22 on Monday, reaching $2.19. The company had a trading volume of 708,676 shares, compared to its average volume of 294,354. The stock has a market capitalization of $19.25 million, a P/E ratio of -0.88 and a beta of 2.05. The company’s fifty day moving average is $1.73 and its 200 day moving average is $2.45. ReWalk Robotics has a 52-week low of $1.25 and a 52-week high of $7.70.

Insider Activity at ReWalk Robotics

In other ReWalk Robotics news, major shareholder Global Fund Lp Lind II sold 381,676 shares of the firm’s stock in a transaction on Monday, January 6th. The shares were sold at an average price of $3.36, for a total value of $1,282,431.36. Following the completion of the sale, the insider now directly owns 1,049,430 shares in the company, valued at approximately $3,526,084.80. This trade represents a 26.67 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director Michael Swinford purchased 16,471 shares of the firm’s stock in a transaction on Wednesday, November 20th. The stock was bought at an average cost of $1.84 per share, with a total value of $30,306.64. Following the completion of the purchase, the director now owns 26,511 shares of the company’s stock, valued at approximately $48,780.24. This represents a 164.05 % increase in their position. The disclosure for this purchase can be found here. Insiders have purchased 61,000 shares of company stock worth $115,279 over the last ninety days. Insiders own 2.50% of the company’s stock.

Analyst Upgrades and Downgrades

Several research analysts have issued reports on LFWD shares. HC Wainwright reiterated a “buy” rating and issued a $13.00 price target on shares of ReWalk Robotics in a report on Wednesday, November 13th. Laidlaw initiated coverage on ReWalk Robotics in a report on Monday, February 10th. They issued a “buy” rating and a $10.00 target price on the stock.

About ReWalk Robotics

ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes technologies that enable mobility and wellness in rehabilitation and daily life for individuals with physical and neurological conditions in the United States, Europe, the Asia-Pacific, and internationally. It offers ReWalk personal exoskeleton and rehabilitation exoskeleton devices; ReStore, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke; AlterG Anti-Gravity System for use in physical and neurological rehabilitation and athletic training; MyoCycle devices; and ReBoot, a personal soft exo-suit for home and community use by individuals post-stroke.